Meningitis B vaccination

A new vaccine to prevent meningitis is being offered to babies as part of the routine NHS childhood vaccination programme.
The Men B vaccine is recommended for babies aged 2 months, followed by a second dose at 4 months, and a booster at 12 months.

There is also a temporary catch-up programme for babies who are due their 3- and 4-month vaccinations in September 2015, to protect them when they are most at risk from infection.

The Men B vaccine will protect your baby against infection by meningococcal group B bacteria, which are responsible for more than 90% of meningococcal infections in young children.

Meningococcal infections can be very serious, causing meningitis and septicaemia (blood poisoning), which can lead to severe brain damage, amputations and, in some cases, death.

Meningitis and septicaemia caused by meningococcal group B bacteria can affect people of any age, but is most common in babies and young children.

The new programme makes England the first country in the world to offer a national, routine and publicly funded Men B vaccination programme.

To read more about the Men B vaccination please visit the NHS Choices website.